The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ADR-201: A novel cytotoxic drug-conjugate for pancreatic cancer.
 
Mark Ricigliano
Employment - Adera BioOncology
Leadership - Adera BioOncology
Stock and Other Ownership Interests - Abbvie; Adera BioOncology; Lilly
Patents, Royalties, Other Intellectual Property - Adera BioOncology; CellPath Therapeutics
 
Brandon Cooper
Employment - Adera BioOncology
 
Andrew Bartlett
Employment - Adera BioOncology
 
Kenneth H. Yu
Consulting or Advisory Role - celgene; Merck Serono; Merrimack